ANA
LLUCH HERNANDEZ
EMÉRITO/A UNIVERSIDAD
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (5)
2019
-
High numbers of circulating CD57+ NK cells associate with resistance to her2-specific therapeutic antibodies in HER2+ primary breast cancer
Cancer Immunology Research, Vol. 7, Núm. 8, pp. 1280-1292
2017
-
Physical activity and breast cancer risk by pathological subtype
Gynecologic Oncology, Vol. 144, Núm. 3, pp. 577-585
2015
-
Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasis
Cancer Research, Vol. 75, Núm. 2, pp. 284-295
2010
-
Phase I study of oral vinorelbine and capecitabine in patients with metastatic breast cancer
Anticancer Research, Vol. 30, Núm. 6, pp. 2255-2261
2005
-
Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with bone metastases (BOMET-QoL)
Journal of Outcomes Research, Vol. 9, Núm. 15-27, pp. 15-27